BiondVax Pharmaceuticals Ltd. announced that all proposed resolutions were approved at the Annual General Meeting of Shareholders, including the election of Mr. Jay Green to the Company's Board of Directors. Mr. Green recently completed a six-year term as Senior Vice President Finance and CFO of GlaxoSmithKline plc's global vaccines business. Concurrently, Mr. Isaac Devash retired from the Board of Directors.